Home » Trials



Trial Title Registration Number Flag
An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel-group, randomised controlled trial to determine the effect of more intensive blood pressure control provided by a fixed low-dose combination blood pressure lowering pill (“Triple Pill”) strategy on top of standard of care, on time to first occurrence of recurrent stroke in patients with a history of acute stroke due to intracerebral hemorrhage. SLCTR/2017/030
A randomised controlled trial to assess the effectiveness of acupuncture in reducing high blood pressure among patients with essential hypertension in the Chitwan district of Nepal SLCTR/2017/029
Effectiveness of Vitamin C in reducing morbidity in patients with Dengue fever - A double blinded randomized placebo controlled pilot study. SLCTR/2017/028
Dysphotopsia following cataract surgery; clinical trial on a preventive surgical approach SLCTR/2017/027
Open label randomized controlled clinical trial to study the effects of achieving lowered uric acid targets with Allopurinol on rate of progression, cardiovascular morbidity and inflammatory markers of Chronic Kidney Disease of uncertain etiology (CKD-u) Sri Lanka SLCTR/2017/026
Effectiveness of a single dose of oral vs rectal paracetamol in reducing fever in children aged between 2 to 6 years – A Randomized Controlled Single Blind Trial SLCTR/2017/025
The efficacy of rupatadine in reducing the incidence of dengue haemorrhagic fever and complications in patients with dengue fever: a randomised, double blind, placebo controlled trial SLCTR/2017/024
Safety and effectiveness of vacuum aspiration, compared to curettage for management of patients with first trimester miscarriage in a limited resource setting in Sri Lanka. SLCTR/2017/023
Community based intervention for primary prevention and control of Non-communicable disease (NCD) risk factors in Ilam and Dhankuta districts, Nepal. SLCTR/2017/022
A multi-center, double-blind, randomized, 24-month study, to compare the efficacy of doxycycline once daily for 6 weeks versus placebo in improving filarial lymphedema independent of active filarial infection SLCTR/2017/021

- Protocol changed - Trial completed - Progress reports not updated - Retrospective trial - Duplicate registration